|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| OPERATING ACTIVITIES: | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Depreciation, depletion, and amortization | |||||
| Impairment of long-lived assets | |||||
| Amortization of deferred financing costs | |||||
| Deferred income taxes | |||||
| Loss on disposition of property, plant, and equipment | |||||
| Stock-based compensation | |||||
| Changes in operating assets and liabilities: | |||||
| Trade receivables, net | |||||
| Inventories | |||||
| Prepaid expenses and other current assets | |||||
| Other assets | |||||
| Accounts payable and accrued expenses | |||||
| Other liabilities | |||||
| Net cash provided by operating activities | |||||
| INVESTING ACTIVITIES: | |||||
| Purchase of property, plant, and equipment | |||||
| Proceeds from sale of property, plant, and equipment | |||||
| Net cash used in investing activities | |||||
| FINANCING ACTIVITIES: | |||||
| Cash dividends paid | |||||
| Proceeds from exercise of stock options | |||||
| Purchase of treasury shares | |||||
| Net cash used in financing activities | |||||
| Net increase in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of period | |||||
| Cash and cash equivalents at end of period | |||||
Loading...